ICEMVO CONTACT DURING SUMMER 2020

By |2020-07-08T10:32:15+00:00July 8th, 2020|

08.07.2020 CONTACT The best way to get in touch with ICEMVO during summer is to send an email. Our office is closed from July 13th to August 4th but monitoring activity of alerts is maintained. Alert Related Questions Email: alerts@lyfjaaudkenni.is General and Technical Questions Email: info@yfjaaudkenni.is Contracts and Fees (MAH) Email: info@lyfjaaudkenni.is Website: https://lyfjaaudkenni.is/ Telephone [...]

EMVO – NEW TECHNICAL DOCUMENT ON ALERT AND NOTIFICATIONS

By |2020-07-03T14:53:35+00:00July 3rd, 2020|

03.07.2020 A new document, EMVO_0402_EMVS Alerts & Notifications, is now available to OBPs. It can be found in the Technical Info Pack on the OBP Portal. The document describes alerts and notifications emanating from the European Medicines Verification System (EMVS). It can be used to help identify the triggers that cause the EMVS to issue [...]

ICEMVO 2020 Annual Fee

By |2019-10-18T14:53:56+00:00October 18th, 2019|

18.10.2019 The ICEMVO annual flat fee is charged per market authorization holder to cover, inter alia, the annual costs of the operation and further development of the ICEMVS, costs inherited from the European Medicines Verification Organization and all necessary and legally compulsory activities of the ICEMVO. The level of the annual flat fee contribution is [...]

September 30th – ICEMVS stabilisation period comes to an end.

By |2019-10-04T10:58:11+00:00October 2nd, 2019|

1st. October 2019 Stabilisation period granted to end-users of the Icelandic Medicines Verification system (ICEMVS) has come to an end as of September 30th, 2019. End-users in Iceland are now required to record, investigate and potentially report alerts received from ICEMVS and the European Medicines Verification System (EMVS). In case of an alert, the end-user [...]

ICEMVO 2019 Annual Fee

By |2019-03-04T12:26:12+00:00March 4th, 2019|

04.03.2019 The ICEMVO annual flat fee is charged per market authorization holder to cover, inter alia, the annual costs of the operation and further development of the ICEMVS, costs inherited from the European Medicines Verification Organization and all necessary and legally compulsory activities of the ICEMVO. The level of the annual flat fee contribution will [...]

Verification of medicines in Iceland from 9th February 2019 – initial stabilisation period or ‘use and learn’ phase

By |2019-02-08T15:49:17+00:00February 8th, 2019|

08.02.2019 The following national approach to the initial operation of the medicines verification system in Iceland has been announced today. The Icelandic Medicines Agency has been working closely with the ICEMVO to monitor progress in the implementation of the new safety feature requirements across all sectors. Notwithstanding the significant work undertaken to date and given [...]

Announcement – Icelandic Medicines Verification System Goes Live

By |2018-05-22T16:00:25+00:00May 22nd, 2018|

14.05.18 We are delighted to announce that on May 14th, the Icelandic Medicines Verification System (ICEMVS) was connected to the European Hub live production environment. Achieving this important milestone was made possible with successful collaboration with colleagues from other NMVO’s working with Solidsoft Reply, especially ZAPAZ in Slovenia, with strong support from the EMVO team [...]

June is last call to start on-boarding the EU-hub

By |2018-02-10T01:00:39+00:00February 10th, 2018|

EMVO is making all On-Boarding Partners (OBP) aware that the end of June 2018 should be considered as the very last opportunity to On-board timely. An On-boarding Partner is EMVO’s designation of a Marketing Authorisation Holder (MAH) who uploads serialized data. EMVO would like to make all On-boarding Partners and future On-boarding Partners aware that [...]

ICEMVO first seminar

By |2017-11-30T18:01:51+00:00November 30th, 2017|

November 30th, 2017 ICEMVO held its first seminar on the introduction of the Icelandic medicine verification system on Wednesday 29 November. The seminar was very well attended, with a total of 80 participants, from pharmaceutical manufacturers and their representatives in Iceland, pharmacies, wholesalers, hospitals, the Icelandic Medicines Agency and local information technology companies. The agenda [...]

Go to Top